This Christmas, Cruciani C is renewing its collaboration with AIL (Italian Association against Leukemia, Lymphoma and Myeloma). A part of the proceeds will be devolved for important research projects to identify the possible family predisposition to different forms of neoplastic diseases of the blood and help patients with acute myeloid leukemia or myelodysplastic syndrome.